🇺🇸 FDA
Patent

US 8604064

Process for the preparation of roflumilast

granted A61KA61K31/44A61P

Quick answer

US patent 8604064 (Process for the preparation of roflumilast) held by TAKEDA GMBH expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/44, A61P, A61P11/00, A61P17/00